Skip to content

Category

gene editing

1,680 papers

#gene editing Open access Sep 2026

NEW AUDIO INTERVIEW - Camilo Fernández Bravo, MD/PhD/FACC, Editor in Chief, on the Future of Clinical and Translational Cardiology

NEW AUDIO INTERVIEW - Camilo Fernández Bravo, MD/PhD/FACC, Editor in Chief, on the Future of Clinical and Translational Cardiology** --- **HOST:** Welcome to our New Audio Interview series. Today we have a true leader in modern cardiology. Dr. Camilo Fernández Bravo, MD, PhD, FACC, Editor in Chief of the Journal of Cli...

Camilo Fernández Bravo · 0 citations
#generative ai Book Sep 2026

AI Models for Advancing Plant Genetics and Genetic Engineering

Artificial intelligence (AI) has emerged as a transformative force in plant genetics and genetic engineering, addressing long-standing challenges in trait complexity, breeding cycle duration, and genome-editing precision. The convergence of machine learning, deep learning, and multi-omics integration enables the decodi...

Subhadwip Ghorai, Suvojit Bose, Ankur Mukhopadhyay et al. · 0 citations
#generative ai Book Sep 2026

AI Models for Plant Systems Biology

Artificial Intelligence (AI) has revolutionized plant systems biology via the possible combination of multi-omics data, higher-order modeling, and autonomous hypothesis construction. Through deep learning, machine learning, and hybrid models, AI interprets complex genotype–phenotype connections and aids predictive mode...

Mani Manoj, Suhana Salim, Ponnusamy Vijay Krishna et al. · 0 citations
#gene editing Sep 2026

CRISPR-Cas9 engineering for high-level β-galactosidase production in Saccharomyces boulardii.

A validated CRISPR-Cas9 strategy for high extracellular β-galactosidase secretion in the clinically established S. boulardii CNCM I-745 is demonstrated, providing a foundation for future studies where the potential of the developed strains is evaluated in clinically relevant settings.

J. Carvalho, David Sáez Moreno, Carlos E. Costa et al. · 0 citations
#gene editing Review Sep 2026

Precision genetic manipulation: CRISPR toolkits reshape plant biology.

Key CRISPR-derived tools are introduced, including base editors, prime editors, and programmable transcriptional and epigenetic regulators, and remaining challenges to stimulate future exploration of the full potential of CRISPR toolkits are outlined.

Zhen-Xiang Li, Xiang-Yu Xiong, Ren-Qi Cao et al. · 0 citations
#gene editing Open access Sep 2026

Development of CRISPR_SCD001, an Autologous Hematopoietic Stem Cell Gene Therapy for Sickle Cell Disease after CRISPR-Cas9 Mediated Correction.

Data support initiation of a first-in-human phase I trial of CRISPR_SCD001 for sickle patients presenting with severe pathology, and generates a clinical-grade, cryopreserved CD34+ cell product that corrects the sickle mutation, restores anti-sickling hemoglobins, and meets pre-clinical safety criteria.

M. DeWitt, Beatriz Campo-Fernández, Sohini Roy et al. · 0 citations
#gene editing Review Open access Jan 2026

Cancer‐Testis Antigens in Immuno Oncology Mechanisms Therapeutic Strategies and Clinical Perspectives

Cancer‐testis antigens (CTAs) represent a unique class of tumor‐associated antigens (TAAs) with highly restricted expression in immune‐privileged tissues and widespread aberrant activation in various malignancies. Their potent immunogenicity and tumor specificity make CTAs promising targets for cancer immunotherapy. Th...

Ran-Ran Shi, Ling Ran, Tian-Tian Song et al. · 0 citations
#gene editing Open access Sep 2026

Tomato DOR encodes a signal peptide peptidase-like protein required for adventitious organogenesis and rooting

It is demonstrated that DOR is the first member of the tomato SPPL gene family known to be associated with root development and adventitious organogenesis and Overexpression of this gene in the mutant has enabled the regeneration of plants with a wild-type phenotype.

M. Jáquez-Gutiérrez, S. Bretones, Constanza Martin-Vásquez et al. · 0 citations
#gene editing Open access Sep 2026

The conversion of a gene-edited cell compartment is rate-limited by host cell turnover, not by the engineered graft

This deposit contains the complete computational model and analysis code for a within-host study of autologous CCR5 gene-edited HIV cure. The work shows that the conversion of a patient's CD4 T cell pool to an HIV-resistant state is rate-limited by the turnover of the patient's own unedited cells rather than by any pro...

Mohammad Hamdallah · 0 citations
#gene editing Open access Sep 2026

ankitgupta83/SpectralKoopman: SKA1.0.0

SpectralKoopman This repository provides an implementation of the Spectral Koopman Approximation (SKA) method for stochastic reaction networks (SRNs). The code accompanies the manuscript: A spectral framework for revealing the hidden low-dimensional structure in stochastic reaction networks Ankit Gupta and Mustafa Kham...

Ankit Gupta · 0 citations
#gene editing Review Sep 2026

Precision Genome Engineering in Human Disease: Expanding Therapeutic Roles of CRISPR Technologies

The advent of CRISPR-Cas9 technology has revolutionized genome editing, enabling precise modifications to the human genome with unprecedented accuracy and sequence specificity. This review examines current mechanistic insights, translational advances, and clinical developments in gene editing, focusing on applications...

Abraham E. Ubhenin, F. Adamude, D. O. Ochalefu et al. · 0 citations

From tech blogs

See all →
Microsoft Research Blog Oct 15, 2026

Proof-based general-purpose computing with Magnetar

Zero-knowledge proofs can verify computing results without rerunning workloads or exposing sensitive data. Magnetar helps bring them into the mainstream with support for standard programming languages, major speed gains, and quantum-resistant security. The post Proof-based general-purpose computing with Magnetar appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.